Search Results

Showing results 2311 - 2320 for weill cornell connect patient portal

Methods for the Efficient Identification of Ubiquitination Sites by Proteomics | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-efficient-identification-ubiquitination

Novel Target and Inhibitors for prevention and treatment of Tuberculosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-target-and-inhibitors-prevention-and

Use of Dabco-Based Compounds as Potassium Channel Blockers and Openers | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/use-dabco-based-compounds-potassium-channel

Improved Cell Culture Media for the Derivation and Maintenance of Murine Embryonic Stem Cells | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/improved-cell-culture-media-derivation-and

Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/irreversible-s1pr2-antagonists-treatment

31P NMR spectra of extremity sarcomas: diversity of metabolic profiles

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/31p-nmr-spectra-extremity-sarcomas-diversity-metabolic-profiles-and-changes-response-chemotherapy

CD36 Inhibition to Reduce Visceral Fat Accumulation and Increase Insulin Sensitivity | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/cd36-inhibition-reduce-visceral-fat-accumulation

A Novel Antiviral Method and Screen for Antiviral Agents | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-antiviral-method-and-screen-antiviral-agents

Method to Isolate Embryonic Stem Cells Directed to Forebrain Interneuron Fate | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/method-isolate-embryonic-stem-cells-directed

Faculty & Staff | Genetic Medicine

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/faculty-staff

Showing results 2311 - 2320 for weill cornell connect patient portal